OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$9.43
+0.06 (+0.64%)
Open$9.37
Previous Close$9.37
Day High$9.52
Day Low$9.16
52W High$16.44
52W Low$6.23
Volume—
Avg Volume2.77M
Market Cap2.09B
P/E Ratio—
EPS$-1.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+501.3% upside
Current
$9.43
$9.43
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 61.41M | 61.22M | 384.00M |
| Net Income | -314,287,297 | -282,012,529 | 56.73M |
| Profit Margin | -511.9% | -486.3% | 14.8% |
| EBITDA | -313,955,374 | -297,365,508 | 95.97M |
| Free Cash Flow | — | — | 61.23M |
| Rev Growth | +0.3% | +0.3% | -3.5% |
| Debt/Equity | 0.11 | 0.11 | 0.35 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |